Design, synthesis and biological activity of rigid cannabinoid CB1 receptor antagonists

被引:59
|
作者
Stoit, AR [1 ]
Lange, JHM [1 ]
den Hartog, AP [1 ]
Ronken, E [1 ]
Tipker, K [1 ]
van Stuivenberg, HH [1 ]
Dijksman, JAR [1 ]
Wals, HC [1 ]
Kruse, CG [1 ]
机构
[1] Solvay Pharmaceut Res Labs, NL-1380 DA Weesp, Netherlands
关键词
benzocycloheptapyrazole; CB1 receptor antagonist; molecular modeling; regiochemistry;
D O I
10.1248/cpb.50.1109
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The design, synthesis and biological activities of potent pyrazole-based tricyclic CB1 receptor antagonists (2) are described. The key synthetic step involves the ring closure of the lithiated alpha,gamma-keto ester adduct (4). The optimal nitroderivative (28) in this series exhibits a high CB1 receptor affinity (pK(i)=7.2) as well as very potent antagonistic activity (pA(2)=8.8) in vitro. The regioselectivity of the pyrazole ring closure is shown to depend strongly on the aromatic substitution pattern of the applied arylhydrazine.
引用
收藏
页码:1109 / 1113
页数:5
相关论文
共 50 条
  • [1] CB1 cannabinoid receptor antagonists
    Barth, F
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 40, 2005, 40 : 103 - 118
  • [2] Cannabinoid CB1 Receptor Antagonists
    Thomas, Brian F.
    DRUG DEVELOPMENT RESEARCH, 2009, 70 (08) : 525 - 526
  • [3] Design, synthesis, and biological evaluation of novel alkenylthiophenes as potent and selective CB1 cannabinoid receptor antagonists
    Tai, Chia-Liang
    Hung, Ming-Shiu
    Pawar, Vijay D.
    Tseng, Shi-Liang
    Song, Jen-Shin
    Hsieh, Wan-Ping
    Chiu, Hua-Hao
    Wu, Hui-Chuan
    Hsieh, Min-Tsang
    Kuo, Chun-Wei
    Hsieh, Chia-Chien
    Tsao, Jing-Po
    Chao, Yu-Sheng
    Shia, Kak-Shan
    ORGANIC & BIOMOLECULAR CHEMISTRY, 2008, 6 (03) : 447 - 450
  • [4] Recent advances in CB1 cannabinoid receptor antagonists
    Lange, JHM
    Kruse, CG
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2004, 7 (04) : 498 - 506
  • [5] Design, synthesis and biological evaluation of piperazine analogues as CB1 cannabinoid receptor ligands
    Song, Kwang-Seop
    Lee, Sung-Han
    Chun, Hyun Ji
    Kim, Jong Yup
    Jung, Myung Eun
    Ahn, Kwangwoo
    Kim, Soo-Un
    Kim, Jeongmin
    Lee, Jinhwa
    BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (07) : 4035 - 4051
  • [6] Toward the Design of Cannabinoid CB1 Receptor Inverse Agonists and Neutral Antagonists
    Reggio, Patricia H.
    DRUG DEVELOPMENT RESEARCH, 2009, 70 (08) : 585 - 600
  • [7] Novel Method for Synthesis of Diarylpyrazole Derivatives as Cannabinoid CB1 Receptor Antagonists
    WU Ying-qiu1
    2. Zhejiang Hisun Pharmaceutical Co.
    Chemical Research in Chinese Universities, 2011, 27 (01) : 66 - 69
  • [8] Towards rational design of cannabinoid receptor 1 (CB1) antagonists for peripheral selectivity
    Fulp, Alan
    Bortoff, Katherine
    Zhang, Yanan
    Seltzman, Herbert
    Snyder, Rodney
    Maitra, Rangan
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (19) : 5711 - 5714
  • [9] Novel Method for Synthesis of Diarylpyrazole Derivatives as Cannabinoid CB1 Receptor Antagonists
    Wu Ying-qiu
    Zheng Guo-jun
    Wang Ya-ping
    Wang Xiang-jing
    Xiang Wen-sheng
    CHEMICAL RESEARCH IN CHINESE UNIVERSITIES, 2011, 27 (01) : 66 - 69
  • [10] CANNABINOID RECEPTOR CB1 ANTAGONISTS: STATE OF THE ART AND CHALLENGES
    Bifulco, Maurizio
    Santoro, Antonietta
    Laezza, Chiara
    Malfitano, Anna Maria
    VITAMINS AND HORMONES: ANANDAMIDE AN ENDOGENOUS CANNABINOID, 2009, 81 : 159 - 189